To view this email as a web page, click here.
 
DIABETES
 
ISMP calls for more insulin pen education after patient death
More education is needed for diabetic patients after a patient died from incorrectly using an insulin pen, according to a new warning from the Institute for Safe Medication Practices.
Read more
 
New diabetes drug set to rival Trulicity
If it is approved by FDA, an investigational drug to improve glycemic control in patients with type 2 diabetes will likely be a strong competitor to Eli Lilly's dulaglutide (Trulicity).
Read more
 
Novel device helps diabetics avoid stress linked to glucose testing
FDA approved the first continuous glucose monitoring system that allows for diabetes treatment decisions without requiring a fingerstick.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.